94 related articles for article (PubMed ID: 2058162)
21. [Changes in parameters of lipid metabolism and anti-oxidative potentials in elderly hyperlipoproteinemic patients treated with omega-3 fatty acids].
Reuter W; Vorberg B; Sauer I; Krumpolt C
Z Gerontol; 1994; 27(3):204-7. PubMed ID: 8091840
[TBL] [Abstract][Full Text] [Related]
22. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients.
Muravyov AV; Yakusevich VV; Surovaya L; Petrochenko A
Clin Hemorheol Microcirc; 2004; 31(4):251-6. PubMed ID: 15567894
[TBL] [Abstract][Full Text] [Related]
23. [Clinico-biochemical validation of the use of PUFA omega-3 in patients with ischemic heart disease, familial hyperlipoproteinemias and hypertension].
Pogozheva AV; Samsonov MA; Levachev MM
Vopr Pitan; 1996; (1):34-6. PubMed ID: 9157710
[TBL] [Abstract][Full Text] [Related]
24. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK; Abbey M; Nestel PJ; Howe PR
J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
[TBL] [Abstract][Full Text] [Related]
25. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
Koltai K; Feher G; Kesmarky G; Keszthelyi Z; Czopf L; Toth K
Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851
[TBL] [Abstract][Full Text] [Related]
26. Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients.
Labios M; Martínez M; Vayá A; Gabriel F; Guiral V; Aznar J
Clin Hemorheol Microcirc; 1999; 21(2):79-85. PubMed ID: 10599590
[TBL] [Abstract][Full Text] [Related]
27. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
[TBL] [Abstract][Full Text] [Related]
28. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.
Harris WS; Sands SA; Windsor SL; Ali HA; Stevens TL; Magalski A; Porter CB; Borkon AM
Circulation; 2004 Sep; 110(12):1645-9. PubMed ID: 15353491
[TBL] [Abstract][Full Text] [Related]
29. Omega-3 fatty acids in the prevention-management of cardiovascular disease.
Simopoulos AP
Can J Physiol Pharmacol; 1997 Mar; 75(3):234-9. PubMed ID: 9164707
[TBL] [Abstract][Full Text] [Related]
30. The effects of KBT-3022, a new anti-platelet agent, on hemorheological properties in guinea pigs.
Yamamoto N; Yokota K; Yamashita A; Oda M
Thromb Haemost; 1995 Jan; 73(1):118-21. PubMed ID: 7740482
[TBL] [Abstract][Full Text] [Related]
31. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients.
Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S
J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668
[TBL] [Abstract][Full Text] [Related]
32. Improving abnormal hemorheological parameters in aging guinea pigs by water-soluble extracts of Salvia miltiorrhiza Bunge.
Hou WC; Tsay HS; Liang HJ; Lee TY; Wang GJ; Liu DZ
J Ethnopharmacol; 2007 May; 111(3):483-9. PubMed ID: 17223298
[TBL] [Abstract][Full Text] [Related]
33. [Effects of cod liver oil as a source of n-3 fatty acids on lipoproteins and blood viscosity in patients with primary hyperlipoproteinemia].
Giorgi AA; Wikinski R; Kartin D; López GI; Schreier L; D'Alessandro G; Paglione AM; Halperin H; Sermukslis de Smud B
Medicina (B Aires); 1988; 48(5):479-86. PubMed ID: 3255039
[No Abstract] [Full Text] [Related]
34. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
[TBL] [Abstract][Full Text] [Related]
35. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
Bennett WM; Carpenter CB; Shapiro ME; Strom TB; Hefty D; Tillman M; Abrams J; Ryan D; Kelley VR
Transplantation; 1995 Feb; 59(3):352-6. PubMed ID: 7871564
[TBL] [Abstract][Full Text] [Related]
36. Acute carbon monoxide poisoning alters hemorheological parameters in human.
Ozturk B; Arihan O; Coskun F; Dikmenoglu-Falkmarken NH
Clin Hemorheol Microcirc; 2016; 61(4):591-7. PubMed ID: 25536918
[TBL] [Abstract][Full Text] [Related]
37. Blood viscosity parameters in coronary heart disease: effect of fish oil supplementation.
Rillaerts E; Van Camp K; Vandewoude MF; Rademakers F; De Leeuw I
Acta Clin Belg; 1989; 44(1):17-23. PubMed ID: 2763779
[TBL] [Abstract][Full Text] [Related]
38. [Effects of prostaglandin E1 on hemorheology in patients with coronary heart disease].
Ma C
Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Apr; 20(2):107-8. PubMed ID: 1473476
[No Abstract] [Full Text] [Related]
39. Erythrocyte deformability and aggregability in patients undergoing colon cancer surgery and effects of two infusions with omega-3 fatty acids.
Bakker N; Schoorl M; Stoutjesdijk E; Houdijk APJ
Clin Hemorheol Microcirc; 2020; 74(3):287-297. PubMed ID: 31658051
[TBL] [Abstract][Full Text] [Related]
40. Effects of fish oil capsules in two dosages on blood pressure, platelet functions, haemorheological and clinical chemistry parameters in apparently healthy subjects.
Bach R; Schmidt U; Jung F; Kiesewetter H; Hennen B; Wenzel E; Schieffer H; Bette L; Heyden S
Ann Nutr Metab; 1989; 33(6):359-67. PubMed ID: 2694923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
